Biodesix Inc

NASDAQ:BDSX   4:00:00 PM EDT
0.28
+0.03 (+12.74%)
7:53:31 PM EDT: $0.28 0.00 (0.96%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)41.36M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$18.49 Million
Adjusted EPS-$0.07
See more estimates
10-Day MA$0.28
50-Day MA$0.36
200-Day MA$1.01
See more pivots

Biodesix Inc Stock, NASDAQ:BDSX

919 West Dillon Road, Suite 100, Louisville, Colorado 80027
United States of America
Phone: +1.303.417.0500
Number of Employees: 273

Description

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.